Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparison of Psychosocial Outcomes Following Tadalafil Once a Day or PDE5 Inhibitor As Needed in Men With Erectile Dysfunction.

NCT00734604 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.

NCT NCT00734604
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00734604 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparison of Psychosocial Outcomes Following Tadalafil Once a Day or PDE5 Inhibitor As Needed in Men With Erectile Dysfunction.
Lead sponsor
Eli Lilly and Company
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2008
Completion date
September 30, 2009
Enrollment
378 (actual)
Sites
37

Conditions

As the registry lists them; a condition with its own page is linked.

erectile dysfunction